Corvus Pharmaceuticals (CRVS) Leases: 2022-2025
Historic Leases for Corvus Pharmaceuticals (CRVS) over the last 4 years, with Sep 2025 value amounting to $927,000.
- Corvus Pharmaceuticals' Leases rose 209.00% to $927,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $927,000, marking a year-over-year increase of 209.00%. This contributed to the annual value of $1.2 million for FY2024, which is 2.44% up from last year.
- As of Q3 2025, Corvus Pharmaceuticals' Leases stood at $927,000, which was down 8.40% from $1.0 million recorded in Q2 2025.
- Corvus Pharmaceuticals' Leases' 5-year high stood at $3.0 million during Q1 2022, with a 5-year trough of $300,000 in Q3 2024.
- In the last 3 years, Corvus Pharmaceuticals' Leases had a median value of $1.1 million in 2025 and averaged $1.1 million.
- In the last 5 years, Corvus Pharmaceuticals' Leases plummeted by 78.92% in 2024 and then skyrocketed by 209.00% in 2025.
- Over the past 4 years, Corvus Pharmaceuticals' Leases (Quarterly) stood at $2.2 million in 2022, then slumped by 48.17% to $1.1 million in 2023, then climbed by 2.44% to $1.2 million in 2024, then skyrocketed by 209.00% to $927,000 in 2025.
- Its last three reported values are $927,000 in Q3 2025, $1.0 million for Q2 2025, and $1.1 million during Q1 2025.